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Abstract
Numerous studies have proposed a connection between gut bacteria populations,
inflammation, and psychiatric disorders, now called the "microbiota-gut-brain axis." This project
explores the commensal bacteria commonly found in the human vagina and gut and the
pathogenic potential of these and other bacteria as they relate to inflammation and psychiatry.
For example, alterations in the abundance of select bacterial phyla is connected to an increase in
pro-inflammatory cytokine production, and there is a correlation between those proinflammatory cytokines and psychiatric health. This project identifies these bacteria and the
pathways through which they influence human health and development. At conclusion,
recommendations are given on ways research in the gut microbiota field may be improved.

Introduction
Links between psychiatric disorders, inflammation, and gastrointestinal disease have
sparked interest in the relationship between the gut and brain and brought about the term “gutbrain axis.” This term refers to the bidirectional biochemical interactions that occur between the
central nervous system and the gut. For example, gastrointestinal disorders are more prevalent in
individuals on the autism spectrum than those in control groups 1. Numerous studies have sought
to measure the levels of certain bacterial phyla in individuals suffering from psychiatric or
inflammatory disorders compared to controls in an effort to establish a relationship between the
two. Many of these studies implicate bacteria as potential agitators that worsen symptoms or as
being complicit in causing the disease. The linkages between gut bacteria and neurological
functioning are referred to as the “microbiota-gut-brain axis” or, in the case of studies examining
genetic compositions of bacteria, the “microbiome-gut-brain axis.” The host and its microbes
together makeup what is known as the “holobiont.” The human holobiont is composed of an
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approximately equal number of bacterial and human cells 2. Because bacteria are so abundant in
humans, understanding their functions and how they can impact the body and mind is critical to
human health.

The Initial Colonization of the Gut Microbiota and the Role of the Maternal
Vaginal Microbiome in Gut Microbiome Development
Introduction
In order to understand the complexity of gut microbial populations, it is critical to
examine where gut bacteria come from. Bacteria are organisms and as such, must come from
existing organisms. Those existing populations come from an individual’s mother, who already
has an established microbiome originating from her own mother that is then further influenced
by environmental factors in everyday life. It was once believed that the fetus was sterile and that
initial colonization of an individual occurred during natural birth as the infant passed through the
vagina, which is rich in bacteria, and that bacteria was only present in utero in cases of
intrauterine infection 3. The maternal vaginal bacteria do contribute to the early colonization of
the gut, but the more recent understanding is that the first bacteria to colonize an individual’s gut
come from the placenta, amniotic fluid, and meconium before birth 4. Therefore, a review of
fetal sources of bacteria and of the maternal vaginal microbiome and factors impacting it is
critical to understanding the development of an individual’s microbiota and early infant health,
which can have lasting impacts on an individual.
Fetal Colonization
The first colonization of the infant gut comes from the placenta, amniotic fluid, and—if it
is released prior to birth thereby coating the fetus in the enclosed womb environment—the
meconium, which is the infant’s first bowel movement 5. Of course the source of these bacteria
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is still the mother, but the exact mechanism of how her bacteria colonize the placenta is
unknown. Interestingly, placental populations most resemble those of the mother’s mouth, so
researchers hypothesize that there may be a way for bacteria in the mother’s mouth to travel
through the blood to the placenta, but this theory is only speculative 5 The placenta provides
blood and nutrients to the infant from the mother via the umbilical cord. Bacteria found in the
placenta include Fusobacteria, Firmicutes, Tenericutes, Proteobacteria, and Bacteroidetes 5.
Additional findings indicate that the dominant bacterial species in the placenta is E. coli. The
amniotic fluid that is ingested once the fetal gut has developed has bacteria. This ingestion of
amniotic fluid is able to directly colonize the gut and contributes to the population of bacteria
found in the meconium. The meconium may act as a source of colonization if it is released prior
to birth or otherwise accesses the infant’s mouth. In one study, 77.08% of neonates had bacteria
in their meconium, and the bacteria found included Staphylococcus, Enterobacteriaceae,
Enterococcus, Lactobacillus, and Bifidobacterium 6. Colonization during the fetal stage is one
factor that determines the earliest compositions of an infant’s gut, but the birth canal further
colonizes it in natural birth.
An Overview of the Vaginal Microbiome
The vaginal microbiome is of particular importance because it is one of the first
colonizers of vaginally delivered neonates’ guts. Before puberty, the vaginal microbiome is
primarily composed of anaerobic bacteria 7. The vaginal microbiome after puberty is typically
dominated by Lactobacillus crispatus, L. iners, L. gasseri, or L. jensenii 8. Lactobacillus species
produce lactic acid, which results in a low vaginal pH and aids in protection against gramnegative pathogenic bacteria and HIV 8. Protection from pathogenic bacteria is important
because they can elicit powerful pro-inflammatory responses by activating toll-like receptors to
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release cytokines 7. If pathogenic bacteria are present, they may be passed to neonates born via
the birth canal. Vaginal bacterial diversity is lowered during pregnancy, and the vaginal
microbiota is dominated by Lactobacillus species, Clostridiales, Bacteroidales, and
Actinomycetales 9. It is believed that the increased levels of Lactobacillus in pregnant women is
correlated with increased levels of estrogen 10. A study by Lewis et al. found the composition of
the vaginal microbiome varies between different ethnicities. This study found African American
women born in the U.S. have greater microbial diversity and a lower abundance of Lactobacillus
than Caucasian women born in the U.S. This difference in populations between ethnicities can
contribute to differences in neonatal microbiotas and could potentially impact infant health. The
implications for neonatal health outcomes stress the importance of a healthy population of
bacteria in the vagina.
Maternal Bacterial Vaginosis and its Effects on Neonates
Bacterial vaginosis is a condition characterized by abnormal bacterial populations in the
vagina. Vaginosis populations have a lowered abundance of Lactobacillus species and a greater
population of anaerobic bacteria 11. Findings also show that bacterial vaginosis in pregnant
women has been linked to premature birth, chorioamnionitis (inflammation of fetal membranes),
low birth weight, an increased risk of NICU admission, and miscarriage. In addition, there is a
60% increase in risk of neonatal sepsis (bacterial blood infection) occurring when the mother has
bacterial vaginosis. This evidence further supports the claim that the vaginal microbiome is key
to infant health.
Maternal Stress and its Impacts on the Maternal Vaginal Microbiome and Infant Health
External factors, such as maternal stress, can also influence the vaginal microbiome. An
experiment performed on mice found that exposure to prenatal stress resulted in an altered
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maternal vaginal microbiota 12. These changes impacted the abundances of amino acids, which
form proteins necessary for biological processes, in offspring. It is important to note that the gut
microbiotas of vaginally-delivered offspring were influenced in a sex-specific manner 12.
Microbiomes being altered in a sex-specific manner may offer explanations as to why certain
illnesses are more prevalent in one sex than the other. Maternal stress can also cause long-term
alterations to the hypothalamic-pituitary-adrenal axis and central nervous system, which play
prominent roles in psychiatric and neurodevelopmental health 13. As is evidenced, the vaginal
microbiome can determine early infant health if the infant is delivered through the birth canal.
Gut Microbiota Development – Method of Infant Delivery
As noted, infants delivered vaginally acquire additional microbes from the birth canal,
and those delivered via cesarean section acquire them from the hospital environment 14. Fullterm infants delivered vaginally have greater gut microbial diversity than preterm infants
delivered via cesarean section 15. Bifidobacterium, Bacteroides, and Escherichia coli are found
in neonates delivered vaginally 14. In a mouse experiment on prenatal stress, it was found that
inoculating mice delivered via C-section with maternal vaginal fluid resulted in gut microbiota
profiles similar to mice delivered vaginally 12. This inoculation can have profound impacts on
the development of the gut microbiome. The method of delivery is a key player in determining
early gut microbial composition.
Gut Microbiome Development – Breastfed vs Formula-Fed Infants
Differences have also been found between formula-fed infants and those given breast
milk from their mothers. Bifidobacterium, Lactobacillus, Staphylococcus, Bacteroides,
Streptococcus, Enterococcus, and Clostridium are found in breast milk 14. Bifidobacteria hold
the majority in breastfed infant intestinal microbiota 16. Infants fed their mother’s milk rather
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than formula or donor milk had an overall greater diversity of gut bacteria 15. Formula-fed
infants have lower levels of Bifidobacterium, which inhibit the growth of pathogens 14. It was
also found that those fed formula or donor milk had a dominance of Enterobacteriales. Diverse
gut microbiota with members of Bifidobacterium, Clostridiales, and Lactobacillales dominating
may protect premature infants from necrotizing enterocolitis 14. Ergo, the method of feeding
impacts an infant’s gut microbial development and health.
Gut Microbiome Development – Maternal & Neonatal Antibiotic Usage
Another impact on early infant health and the developing microbiome is antibiotic usage.
Premature infants whose mothers were given antibiotics while pregnant with them or who
received antibiotics directly after birth had a narrower diversity of bacteria when compared to
those who were not exposed to antibiotics 14. The gut bacteria found in infants exposed to
antibiotics consisted only of Enterobacter, Escherichia, Enterococcus, and Staphylococcus 14.
Lowered microbial diversity has been associated with diseased states and could therefore be
dangerous to infant health.
Gut Microbiome Development – The Birthing Environment
The birthing environment plays a role in early gut colonization as well. Environmental
factors include contact with medical personnel and time spent in the NICU, but the exact impact
on the infant’s gut microbiota has yet to be determined 14.
Summary of Gut Microbiota Development
The development of the microbiome begins prior to birth. The placenta, amniotic fluid,
and meconium all contribute to fetal gut microbiome colonization. If the infant is delivered via
the birth canal, vaginal bacteria play a major role in early gut microbiota development.
Dysbiosis of the vaginal microbiota can in turn negatively impact infant health. This finding
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makes vaginal health critical to infant health and perhaps even future health outcomes. Infants
born via C-section have different bacteria because they do not go through the vagina, and their
microbiomes tend to be shaped more by the environment into which they are born. Exposure to
antibiotics before or after birth, the type of food, and the environment in which the infant is born
also impact early development. Understanding the initial colonization of the gut microbiome
aids in the understanding of later development and potential consequences of dysbiosis.

Typical Gut Microbiota & Variables Impacting Composition
Introduction
A healthy population of gut bacteria is conducive to an individual’s well-being. One of
the greatest difficulties faced by researchers is establishing what constitutes an ideal gut
microbiome. This problem exists because gut bacterial populations vary considerably from
person to person. Factors that can impact the development and maintenance of the gut
microbiome include the environment, age, genetics, gender, diet, and antibiotic use. Despite
these variables, there are bacterial phyla that appear consistently in subjects from a variety of
studies. These observations point towards a basic composition of common gut bacteria.
Overview of Commensal Gut Microbiota Populations
The gut contains a diverse array of bacteria with varying populations that are dependent
upon the area of the gut examined. The colon contains 1014 bacteria and has the highest
abundance of bacteria of any human organ 2. The lower small intestine harbors 1011 bacteria 2.
The upper small intestine and stomach each have 107 bacteria 2. These microorganisms aid in
digestion, metabolism, and immunity. Human gut microbiomes vary based on geographic
location, diet, genetics, gender, age, and usage of antibiotics, but there is a 40% similarity in
intestinal microbial gene composition amongst at least half of the individuals in the general
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population 17. Both gram-positive and gram-negative bacteria are found in the gut. Gramnegative bacteria have a cell wall with a thin layer of peptidoglycan and are generally associated
with pathogenicity. Gram-positive bacteria have thick layers of peptidoglycan. More than 90%
of the bacteria in the gut belong to the phyla Bacteriodetes and Firmicutes 18. Bacteriodetes are
gram-negative, and Firmicutes are mostly gram-positive. Other than Bacteroidetes and
Firmicutes, major commensal gut bacterial phyla include Actinobacteria, Proteobacteria, and
Fusbobacteria 16. Major genera include Bacteroides (phylum Bacteriodetes), Prevotella
(Bacteroidetes), and Ruminococcus (Firmicutes) 19. Bifidobacterium (phylum Actinobacterium)
and Lactobacillus (phylum Firmicutes) are commonly found in the intestines 16. The exact
abundances of these bacteria vary from individual to individual. Three different enterotypes
have been proposed to classify human populations based on their gut bacteria: Enterotype I is
enriched in Bacteroides, Enterotype II has a greater population of Prevotella and Desulfovibrio,
and Enterotype III has high levels of Ruminococcus 20. Which enterotype an individual has is
determined both by lifestyle and biological factors.
Environment
One factor in determining the composition of the gut microbiome is exposure to green
spaces. Urban environments deprived of green spaces have less microbial diversity than the
natural environment 21. This lack of bacterial diversity in the external environment results in
lowered exposure to diverse microbes and in turn leads to a less diverse gut microbiome. Studies
comparing the prevalence of inflammatory bowel disease, which is connected to gut microbial
composition, in urban and rural environments found that there is a higher incidence of
inflammatory bowel disease in urban environments due to the lowered exposure to green spaces
13

. Differences in environments can also be seen at an international level, which may be
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explained by cultural differences that impact time spent outdoors or the geographic location. In a
Japanese study, researchers found that Japanese adults have higher levels of the genera Blautia
and Bifidobacterium and lower levels of Bacteroidetes than adults in other countries 22. It is
important to note that cultural differences in diet could also contribute to differences between
nations.
Diet and Obesity
Diet is another major determinant in gut microbiota composition. Protein-rich diets are
associated with enterotype I, and carbohydrate-rich diets are associated with enterotype II 23. In
mouse models, diets high in fat (Western diets) increased the prevalence of Proteobacteria and
decreased the abundance of Bacteroidetes 23. Diets high in fiber and carbohydrates have been
found to lower the abundance of pathogenic bacteria in the families Enterobacteriaceae and
Bacteroidaceae 23. Children from Burkina Faso, where high fiber diets are prominent, had a
lower ratio of Firmicutes to Bacteroidetes than European children 24. Burkina Faso subjects also
had higher levels of short-chain fatty acids 24. One possible problem with this particular study is
the difference in environments: a rural African village as opposed to a European “environment
typical of the of the developed world 24.” The differences in exposure to green spaces could have
introduced a variable other than diet to this study.
Dietary impacts on the gut microbiome can also be seen by examining gut populations in
obese individuals. Obese subjects have a different microbiota composition than lean subjects 25.
When microbiota transplants from obese humans to germ-free mice were performed, the mice
gained weight 25. These differences are reflected when comparing the prevalence of bacterial
species in lean mice to those in obese mice. Obese mice have a higher ratio of Firmicutes to
Bacteroidetes 26. Obese humans mirrored these findings and have a lower microbial diversity
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than non-obese individuals 26. This finding is fascinating because Firmicutes produce butyrate,
which is considered anti-obesogenic, and Bacteroidetes produce propionate, which is obesogenic
26

. In addition, future obesity could be predicted by examining the gut microbiome. Six month

old infants with a low abundance of Bifidobacterium and an increased abundance of
Staphylococcus aureus were found to be at an increased risk of being overweight when they
reached the age of seven 26. This finding supports a connection between obesity and the gut
microbiome.
Age
Age is another important factor in microbiota composition. A Japanese study examined
367 healthy subjects between zero and 104 years old to see what differences could be found in
their microbiotas 22. Actinobacteria, the phylum to which Bifidobacterium belongs, decreased
substantially over time after weaning 22. This outcome is unsurprising given that a high
abundance of Bifidobacterium is associated with infants being breastfed 16. After age 3, the gut
microbiome becomes more stable and is reflective of the adult microbiome 14. Bacterial
diversity increases from this post-weaning age until the twenties 22. Changes occur again upon
individuals reaching senior status. Bacteroidetes and Proteobacteria increased after the age of
70, and the elderly also have much higher levels of Bacteroidetes, Betaproteobacteria, and
Deltaproteobacteria 22. This evidence demonstrates that the gut microbiome varies by age.
Genetics
Genetics is believed to play a role in the composition of the microbiome, but more
research must be done before concluding the exact impacts of genes on microbiota composition.
There is some debate about the degree to which genetics influences the microbiota. Part of a
study conducted by Turnbaugh et al. found that adult monozygotic twins are not more similar
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than dizygotic twins in terms of microbial populations, which suggests that genetics may not be a
major component in determining microbial makeup 27. On the contrary, some child studies
comparing monozygotic and dizygotic twins have found that monozygotic twins are more similar
in terms of gut microbial composition than dizygotic twins or unrelated individuals 14. One
possible explanation for this discrepancy is the age of the subjects. Adult twins will likely live
separately and therefore have different environmental exposures and diets, which can influence
the gut microbiota’s composition. On the other hand, children will likely be living in the same
household and have similar diets and other lifestyle factors. Still to the contrary, one study
examining data from the Human Microbiome Project found the gut microbiome was an
exception to relatives having more similar microbiomes than when compared to non-relatives 28.
More research is needed to determine the magnitude of the genetic role in microbiome
compositions.
Gender/Sex
Gender plays a role in gut microbial composition. A study of pre-term infants found that
in the first ten days of life, females had a more diverse microbiota than males 15. The same study
found that male premature neonates had microbiomes dominated by Enterobacteriales, and
females tended to have Clostridiales and Lactobacilliales in the majority 15. Because these
differences are found very early in life, the causes of this discrepancy are most likely biological
and not the result of differences in cultural gender-roles. In post-menopausal women and
similarly aged men, there are differences found between the genders at the genus level 29.
Bilophila was found in greater abundance in women, and Veillonella and Methanobrevibacter
were greater in men 29. As evidenced by these studies, gender is an important factor in
determining gut microbiome composition.
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Summary of Typical Gut Microbiota & Variables Impacting Composition
The gut microbiome contains a variety of bacteria. This gut bacterial habitat is
dominated by Firmicutes and Bacteroidetes. Because there are many factors that influence the
composition of a gut microbiota, it is difficult to establish what constitutes an “ideal” gut
microbiota. Lifestyle factors, such as exposure to green spaces and diet, and biological factors,
such as age, gender, and genetics, influence the bacterial populations within the gut. Knowing
what factors can affect the gut microbiome can give important insights into the role the gut
microbiome plays in human health and could potentially lead to treatments for a variety of
illnesses.

Inflammatory Response
Introduction
The gut microbiome is able to influence human health through inflammation.
Inflammation is an immune response that can be invoked by bacteria the body views as
pathogenic. This response is considered healthy except when exaggerated or chronic. The
mechanism by which gut bacteria cause inflammation depends upon the type of bacteria. The
products of these responses to gut bacteria are not necessarily confined to the gut environment,
which helps with understanding how gut bacteria are able to impact other areas of the body.
Inflammation – Gram Negative
An example of how bacteria can lead to inflammation is the toll-like receptor 4 (TLR4)
response to lipopolysaccharide (LPS). Gram-negative bacteria have LPS in their outer
membranes. The lipid A portion of LPS is considered highly toxic. The response of the immune
system to LPS may depend upon the shape of its Lipid A, which varies depending upon the
species of bacteria. Conically-shaped LPS activate TLR4, but cylindrically shaped LPS activates
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TLR2 and can act as an antagonist to the actions of TLR4 30. LPS binding protein binds to the
lipid A moiety—whether LPS is still bound to the bacteria or free--and then forms a ternary
complex with CD14 30. CD14 may be free in the plasma or membrane-bound to myeloid cells 30.
CD14 then presents LPS to the MD-2 and TLR4 complex 30. Lipid A binds to MD-2, which
triggers TLR4’s signal transduction 30. TLR4 is able to signal to internal cellular components
because it is a transmembrane protein. The steps that occur after TLR4 signal initiation are
beyond the scope of this paper, but ultimately lead to NF-κB activating the production of proinflammatory cytokines, such as IL-6 31.
Inflammation – Gram Positive
It is a high ratio of the mostly gram-positive Firmicutes to the gramnegative Bacteriodetes that results in increased levels of interleukin 6, TNF-alpha, and other
markers of inflammation (Chrobak, Nowakowski, & Dudek, 2016). This finding indicates that
gram-positive bacteria are likely also playing a pro-inflammatory role. Gram-positive bacteria’s
lipoteichoic acids and peptidoglycan are the suspected agonists of cytokine release as described
by Moreillon and Majcherczyk 33. Trimers and more complex substructures of peptidoglycan
have been found to elicit the release of tumor necrosis factor from peripheral blood monocytes.
Peptidoglycan binds to CD14, but instead of using TLR4, it uses TLR2. The mechanism after
TLR2 signaling is initiated is similar to that of the TLR4 signaling cascade. It is important to
note that it takes a concentration of 100-1000 times as much lipoteichoic acid or peptidoglycan
to evoke the same response as a given amount of LPS. The strength of inflammation is
independent of pathogenicity. Also of note is that the peptidoglycan substituents found to be
inflammatory are kept “hidden” from host recognition and must be exposed by endogenous wall
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remodeling, hydrolysis, or bacterial lysis. Through this mechanism, gram-positive bacteria are
able to cause inflammation.
Inflammation – Flagellin
Another way for host immune cells to detect bacteria is through the presence of flagellin.
Flagellin is a protein found in flagella, whip-like projections on some bacteria used for motility.
TLR5 is responsible for the detection of flagellin as described by Sang et al. 34. The TLR5
pathway activates NF-κB and activator protein 1, which leads to the production of proinflammatory cytokines, such as IL-8.

Figure 1. This image illustrates the activation and signaling pathways of TLR4, TLR2, TLR5,
and other toll-like receptors not discussed in this paper 31.
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Inflammatory Bowel Diseases
Further supporting the role of bacteria in inflammation, dysbiosis of gut microbiota has
been implicated in inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis.
In adults with active ulcerative colitis or Crohn’s disease, the abundance of Faecalibacterium
prausnitzii is lower than in healthy controls 35. F. prausnitzii produces butyrate, a short-chain
fatty acid that down-regulates production of pro-inflammatory cytokines 36. There is a
substantial reduction in the population of Roseburia hominis, which also produces butyrate, in
both of these inflammatory bowel diseases as well 36,37. Another distinction between healthy
guts and those with inflammatory bowel disease is that significantly higher levels of
Lactobacillus and E. coli were found in the colonic mucosae of ulcerative colitis patients 38.
Inflammatory bowel disease increases the risk of developing colorectal cancer, so differences
between those with colorectal cancer and those without may also provide insight into which
bacteria may result in harmful inflammatory responses. A study examining subjects with
colorectal cancer found that those afflicted have a higher abundance of the genera
Fusobacterium and Porphyromonas 39. As expected due to the relationship between
inflammatory bowel disease and colorectal cancer, this study also found colorectal patients have
lower concentrations of Faecalibacterium. Gastrointestinal inflammation is more prevalent in
subjects afflicted with psychiatric disorders than in controls. Post-mortem research on the
correlation between schizophrenia and gastrointestinal inflammatory disorders found that 88% of
deceased schizophrenics had enteritis, 50% had gastritis, and 92% had colitis 32.
Summary of Inflammatory Response
The gut microbiome is capable of causing an inflammatory response. When the presence
of certain bacterial components is detected by the immune system, toll-like receptor signaling
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cascades cause the production of pro-inflammatory cytokines and other markers of inflammation.
Chronic inflammation is correlated with diseased states and can be detrimental to health. An
example of harmful inflammation can be seen in inflammatory bowel disease, which research
shows is likely linked to the lowered abundance of butyrate-producing bacterial species36. It is
evident that there is a relationship between the bacteria present in the gut and the inflammatory
response, and this information may be useful in treating chronic inflammation.

Microbiota-Gut-Brain-Axis Pathway
Introduction
With an understanding of how dysbiotic gut bacteria result in the production of proinflammatory cytokines, it is possible to see how the gut microbiome is able to influence
psychiatric functioning. This pathway begins in the gut and requires the circulatory system to
reach the brain. Examining bacterial products, such as hormones, gives an even clearer picture
of how the bacteria in the gut can influence cognition. The theory that gut bacteria are able to
affect psychiatric functioning is supported by evidence of gut dysbiosis in those suffering from
depression, autism, and psychosis.
Leaky Gut
Bacterial products produced in the gut are able to affect other areas of the body due to a
phenomenon commonly known as “leaky gut.” “Leaky gut” refers to an increased permeability
of the intestinal epithelium, which separates the contents of the intestines from the rest of the
body. There is an inner and an outer layer of mucus atop the intestinal epithelium that serve to
separate the intestinal epithelium from direct contact with microbes in the intestinal lumen 40.
Gut bacteria inhabit the outer mucosal layer 40. The mucosal layers and single layer of epithelial
cells form a selectively permeable barrier that regulates what substances are able to leave the
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intestinal lumen and enter into the bloodstream to circulate throughout the body 41. Proinflammatory cytokines, such as those secreted in response to gut bacteria, have been found to
increase intestinal permeability 40. This effect of pro-inflammatory cytokines on intestinal
permeability is evidenced by patients with inflammatory bowel disease having a mucosal layer
that is more easily penetrated by bacteria 40. If bacterial products are able to make contact with
the intestinal epithelium, it could elicit an immune response and result in the release of proinflammatory cytokines 42. Individuals with schizophrenia or autism have been found to have
increased intestinal permeability, which supports a link between “leaky gut” and psychiatric
dysfunction 42.
HPA Axis
A key component to how the gut microbiome is able to influence neurological
development and psychiatric health is found in the hypothalamic-pituitary-adrenal (HPA) axis.
Circulating inflammatory cytokines, which can be produced in response to the presence of gut
bacteria and enter circulation because of increased intestinal permeability, cause the
hypothalamus to produce corticotropin-releasing hormone according to a review on the matter 43.
Corticotropin-releasing hormone then prompts the pituitary gland to make adrenocorticotropic
hormone. Adrenocorticotropic hormone stimulates the adrenal glands to produce cortisol.
Cortisol is then able to inhibit the production of pro-inflammatory cytokines and to encourage
the production of anti-inflammatory cytokines 44. This finding offers a potential target in
regulating the impacts of cytokines.
Bacterial Products
With an understanding of how bacterial products produced in the gut are able to affect
other areas of the body, the products and their effects become pertinent. Approximately 95% of
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serotonin, which plays key roles in cognitive functioning, is made in the gut 45. Gut bacteria also
produce the short-chain fatty acids acetate, propionate, and butyrate, which play key roles in
reducing inflammation. Acetate and propionate are produced by bacteria belonging to the phyla
Bacteroidetes, and butyrate is produced by bacteria in the phyla Firmicutes 26. Cytokines, which
can be produced in response to the presence of certain bacteria, are able to alter the permeability
of the blood-brain barrier, which controls the passage of substances between blood and the brain
46

. In addition, short-chain fatty acids produced by some gut bacteria are able to cross the blood-

brain barrier 46. This ability to cross the blood-brain barrier is necessary in order to affect
neurological functions. These products and others are given along with their functions in Table
1 and Table 2.
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Name

Taxonomic

Gram

Product(s)

Classification

+/-

Bifidobacterium

Genus

+

GABA4

Lactobacillus

Genus

+

GABA4,
Acetylcholine32

Species

+

Butyrate36

Roseburia hominis

Species

-*

Butyrate36

Streptococcus

Genus

+

Serotonin32

Escherichia

Genus

-

Serotonin32,

Faecalibacterium
prausnitzii

Norepinephrine32
Enterococcus

Genus

+

Serotonin32

Clostridium

Genus

+

Butyrate, Propionic
Acid47

Bacillus

Genus

+

Dopamine32,
Norepinephrine32

Serratia

Genus

-

Dopamine48

Desulfovibrio

Genus

-

Propionic Acid47

Bacteroidetes

Phylum

-

Acetate26, Propionate26

Firmicutes

Phylum

mostly +

Butyrate26

Table 1: This table displays bacteria commonly found in the gut, their taxonomic classifications,
gram-staining results, and their products. *Roseburia hominis can be either gram-negative or
gram-variable.
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Product

Classification

Function/Effects

Acetate

SCFA

Anti-inflammatory49, Obesogenic26

Acetylcholine

Neurotransmitter

Attention, Learning, Memory

Butyrate

SCFA

Anti-inflammatory49, Antiobesogenic26

Dopamine

Neurotransmitter

Reward/Motivation, Emotion,
Movement

GABA

Inhibitory

Behavior

Neurotransmitter
Norepinephrine

Neurotransmitter

Stress Response ("Fight or Flight")

Propionic Acid,

Carboxylic Acid,

Anti-inflammatory49, Anti-

Propionate

SCFA

obesogenic26

Serotonin

Neurotransmitter

Sleep, Appetite, Mood, Cognitive
Functions

Table 2: This table lists the products of bacteria with their classifications and functions.
SCFA = Short-Chain Fatty Acid.

Summary of the Microbiota-Gut-Brain Axis Pathway
Gut bacteria are able to impact the brain through the circulatory system. Increased
intestinal permeability allows for cytokines and bacterial products to enter the bloodstream.
From there, products are able to reach other areas of the body including the brain. The exact
impacts vary based on the functions of the product. Combining knowledge of the abundance of
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gut species in dysbiotic states with the roles of corresponding bacterial products allows for a
greater understanding of how gut bacteria are able to influence neurological functioning.

Microbiota Composition in Psychiatric Disorders
Introduction
With the pathway between the gut and brain established, it becomes clear that gut
bacteria can play a role in psychiatric function. Examining the differences in the gut microbiota
found between healthy subjects and those afflicted with psychiatric disorders can point towards
potential targets for treatment. Although further research is needed to establish causal roles for
specific gut bacteria, these findings provide insight into the links between the gut and brain. The
disorders discussed include major depressive disorder, psychosis, and autism.
Depression and Anxiety
Dysbiosis of gut microbiota has been observed in patients experiencing major depressive
disorder (MDD). Major depressive disorder is characterized by a lack of motivation in daily life
and depressed moods. There is evidence that the gut microbiome could play a causal role in
MDD. In one study, fecal samples were taken from healthy patients and from patients diagnosed
with MDD 50. Germ-free mice then received a fecal microbiota transplant from either healthy
samples or MDD samples 50. Mice that received a MDD sample exhibited symptoms of
depression and anxiety 50. It was also found that MDD patients had a higher abundance of
Actinobacteria and a lower abundance of Bacteroidetes 50. A different study found that patients
with active MDD had a lower abundance of Actinobacteria and a higher abundance of
Fusobacteria, Bacteroidetes, and Proteobacteria 51. A key difference between these two studies
is that the fecal microbiota transplant study’s MDD subjects were primarily drug-naïve, and the
conflicting study reported widespread atypical antipsychotic, SSRI, SNRI, and benzodiazepine
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usage amongst its MDD subjects 50,51. A review of existing studies on antidepressants found that
some antidepressants have antimicrobial activity, which could explain the inconsistencies in
studies that do not control for antidepressants 52. Regardless of whether or not bacterial
populations increased or decreased in abundance, key differences were observed between healthy
patients and those with MDD.
In a less direct way, another connection can be drawn between gut microbiota and
depression: inflammation. Pro-inflammatory cytokines may release neuroendocrine hormones
that activate the hypothalamic-pituitary-adrenal axis 53. Higher levels of IL-6, tumor necrosis
factor-α, and acute phase proteins have been found in depressed patients 54. The injection of a
pro-inflammatory cytokine, interferon-α, resulted in depression 55. Microbiota may also alter the
permeability of the blood brain barrier 54. These findings reinforce the connection between
depression and gut bacteria.
Psychosis
Psychosis is a psychiatric disorder characterized by a loss of touch with reality.
Compared to controls, subjects experiencing their first episodes of psychosis have been found to
have a greater abundance of Lactobacillus, Halorubrum, Deferribacter, Tropheryma,
Halothiobacillus, Saccharophagus, and Ochrobactrum 56. These subjects also had a lower
abundance of Anabaena, Gallionella, and Nitrosospira 56. Lactobacillus group bacteria
(Lactobacillus, Leuconostoc, Pediococcus, and Weissella) were found to increase with symptom
severity 56. Bacteroides spp., Lachnospiraceae, and Ruminococcaceae became less abundant as
functionality increased 56. The prevalence of bacteria varying with psychiatric functioning
supports a connection between psychosis and the gut microbiome.
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Autism
Autism is a neurodevelopmental disorder characterized by impaired social functioning.
With no clear cause, autism is thought to be the result of a combination of factors. One factor
researchers have taken interest in is the gut microbiome. When compared to healthy controls,
individuals with autism spectrum disorder have a higher incidence of inflammatory bowel
disease, diarrhea, constipation, gastric reflux, and abdominal pain 1. Because of the high rate of
comorbidity between autism and gastrointestinal issues, researchers have looked to the
microbiota of those on the autism spectrum. Autistic patients have an increased Firmicutes to
Bacteroidetes ratio, which has been shown to result in an increase of inflammatory markers 1,32.
There is a greater abundance of LPS and pro-inflammatory cytokines in children with autism,
which supports the theory of a link between gut microbiota populations and autism 42.
Lactobacillus, Desulfovibrio, Sutterella, and Clostridium are increased in autistic patients, and
the abundance of Lactobacillus and Desulfovibrio were positively correlated with autism severity
1

. Autistic patients have decreased levels of propionate, butyrate, and acetate according to this

same report. This observation contradicts other reports that state short-chain fatty acids, such as
propionic acid, are overproduced in those with autism 47. This finding of increased propionic
acid makes sense given that propionic acid is produced by Clostridium and Desulfovibrio, which
are more prevalent in those afflicted with autism 1,47. There is also a reduced abundance of
Coprococcus, Prevotella, and Veilonellaceae, which are necessary for the degradation of
carbohydrates and fermentation 1. In one mouse study, treatment with Lactobacillus reuteri
restored social behaviors 1. Treating these mice in early life with Bacteroides fragilis reduced
autistic behaviors. Regarding children with regressive autism, the phylum Firmicutes was
increased, and the phyla Bacteroidetes, Actinobacteria, and Proteobacteria were decreased 47.
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Even with present evidence, more research must be done to establish the exact role the gut
microbiome plays in autism.
Summary of Gut Microbiota Composition & Psychiatric Disorders
The gut microbiome is an area of active interest in psychiatric research. This interest is
due to the prevalence of chronic inflammation and gastrointestinal dysfunction being comorbid
with psychiatric disorders. There is potential for new treatment methods using the composition
of the gut microbiome, but more research is necessary.

Limitations of Research & Methods for Future Studies
Introduction
In order for studies on the gut microbiome to be meaningful, the methods by which
research is conducted must be scrutinized. Although human studies are not uncommon, mouse
studies are more easily performed and constitute a significant portion of studies on the gut
microbiome. These studies are often used to inspire human studies or to gain insight into factors
that could negatively impact the health of the holobiont. Regardless, mouse study findings
cannot always be translated to human studies, and this case is especially so when dealing with
something as delicate as the gut microbiome. Reading through numerous reviews and
experimental studies also makes it clear that greater consistency in procedures is needed.
Inconsistencies in the types of bacteria examined makes it difficult to find studies that can be
directly compared. Small sample sizes can also make findings questionable. Careful
consideration should be given when determining how to best examine the microbiome so that
results may be efficiently communicated.
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The Advantages and Disadvantages of Mouse Studies
Germ-free mice are popular model organisms for studying the impacts of changes to the
human microbiome. In general, germ-free mice have been found to be more prone to
inflammatory disorders and behaviors associated with abnormal psychiatric profiles than mice
with a typical mouse microbiome, which supports the overarching theory of the influence of the
microbiome on inflammation and psychiatric health. Humanized gnotobiotic mice are of
particular interest in gut microbiota studies because they are born germ-free and then inoculated
with human gut microbiota 57. This is done in hopes of replicating the human microbiome
without the added difficulties associated with using human subjects. Nguyen et al. finds in their
review that the advantages of using mouse models include the low cost, genetic consistency as a
result of inbreeding, comparable anatomy to humans, and fewer restrictions on medical
interventions and experiments than using humans 57. This review of lab animal usage also found
that the homogeny of lab mice populations has its drawbacks: two lab mice will be far more
similar than two humans because mice will have similar genetics, diets, and be raised in similar
environments, whereas humans will have far more variability. Because everything is so
consistent in lab mouse populations, changes made to the mice’s microbiotas will likely impact
all of the mice in a similar way, but because humans have far more lifestyle and biological
variables that cannot be as easily controlled, changes made to human microbiomes may have
different impacts from subject to subject. There are even disadvantages to using humanized
gnotobiotic mice; some microbial species of lower abundance are lost after being transferred to
the mouse models, and although low in number, these bacteria are believed to play a vital role in
the gut microbiome 57. This is just one of many struggles encountered by microbiota researchers.
Inconsistencies Amongst Studies in Bacteria Examined
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One of the greatest hindrances encountered in studying the microbiome is the
inconsistency of methods between studies. Some studies focus on bacteria that are low in
abundance but could potentially have large impacts, such as the psychosis study discussed.
Other studies focus on alterations in the abundance of major commensal bacteria that can be
found in almost every subject. This leads to fewer studies with comparable results because the
bacteria tested for are entirely different. This is further complicated when studies examine
bacteria at different taxonomic levels because a bacterial phylum could be found less abundant as
a whole, but a genus or species within that phylum may be significantly increased in prevalence.
This could lead to the appearance of inconsistent findings. Without several studies examining
the same populations of bacteria, it is difficult to establish a causal role for gut bacteria in
psychiatric disorders and inflammation. In addition, many studies have small sample sizes,
which makes it difficult to find statistically significant data.
The Additional Complication of Medication in Psychiatric Studies
Examining correlations between psychiatric disorders and gut bacteria provides
additional challenges. One such challenge is trying to control for medication usage while still
having a large enough sample size to be statistically significant. Studies have shown that certain
antidepressants may have antimicrobial properties, so those receiving treatment for depression
may have altered gut bacteria that do not accurately represent bacteria influencing their
depressive states 52. Taking patients off of medications for the sake of studies could prove
detrimental to their health and is unethical. In addition, taking patients off of these medications
will not necessarily restore the gut microbiome to its state before medication was introduced.
The best way to handle this is to examine which psychiatric medications have beneficial or
detrimental effects on gut bacterial populations. Subjects on these medications can then either be
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excluded from the study or put into a subgroup to be compared to those who are drug naïve or on
different medications. Whatever route is taken when examining groups with medications as a
variable, it is imperative for the study to discuss the possible influences medications may have
had on results.
Summary of Limitations of Research & Methods for Future Studies
Research on the gut microbiome is gaining traction, but it still has a long way to go
before specific bacterial populations can be implicated as having a causal role in inflammation
and psychiatric disorders. Although mice can provide a basis for conducting studies on humans,
findings in the mouse gut microbiota may not translate to the human gut microbiota. It is
imperative that researchers bear this in mind when examining studies on model organisms.
Studies performed to examine bacterial populations and how they relate to the diseased state
should test for bacteria that have been observed in other studies in order to strengthen or weaken
evidence of causal roles. Testing for bacteria not previously examined can lead to new insights
regarding the gut microbiome, but these findings must be considered with caution because of the
inability of researchers to control every variable that contributes to microbial composition.

Conclusion
The gut microbiome plays a key role in regulating inflammatory responses and in
influencing psychiatric health. This conclusion is supported by studies examining pathways
through which these influences occur and by studies examining gut bacterial populations and
their secretions in relation to inflammation and psychiatric disorders. Many findings are based
on mouse studies, but these studies are not without their disadvantages. In addition, studies tend
to examine the microbiome at different taxonomic levels, which can cause complications when
trying to compare results of multiple studies. Variables that may be difficult to control without
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severely hindering sample size, such as medication usage, provide additional challenges.
Regardless, the evidence presented by current studies still overwhelmingly supports connections
between the microbiome and inflammation and psychiatry. In order to draw more precise
conclusions and establish detailed causal roles, more research is necessary.
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